BR112021014944A2 - Toxinas apxia, apxiia e apxiiia inativas - Google Patents

Toxinas apxia, apxiia e apxiiia inativas

Info

Publication number
BR112021014944A2
BR112021014944A2 BR112021014944A BR112021014944A BR112021014944A2 BR 112021014944 A2 BR112021014944 A2 BR 112021014944A2 BR 112021014944 A BR112021014944 A BR 112021014944A BR 112021014944 A BR112021014944 A BR 112021014944A BR 112021014944 A2 BR112021014944 A2 BR 112021014944A2
Authority
BR
Brazil
Prior art keywords
toxins
inactive
apxiiia
apxia
apxiia
Prior art date
Application number
BR112021014944A
Other languages
English (en)
Inventor
Fabian Deutskens
Heiko Pidde
Sebastian Stentzel
Volker Florian
Original Assignee
Ceva Sante Animale S A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ceva Sante Animale S A filed Critical Ceva Sante Animale S A
Publication of BR112021014944A2 publication Critical patent/BR112021014944A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/285—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pasteurellaceae (F), e.g. Haemophilus influenza
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/102—Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Abstract

toxinas apxia, apxiia e apxiiia inativas. são divulgadas as toxinas apxia, apxiia e apxiiia inativas, vacinas compreendendo as ditas toxinas inativas e a sua utilização para a imunização e proteção de mamíferos.
BR112021014944A 2019-01-30 2020-01-30 Toxinas apxia, apxiia e apxiiia inativas BR112021014944A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP19154466.7A EP3689373A1 (en) 2019-01-30 2019-01-30 Inactivated apxia, apxiia and apxiiia toxins
PCT/EP2020/052334 WO2020157222A1 (en) 2019-01-30 2020-01-30 Inactivated apxia, apxiia and apxiiia toxins

Publications (1)

Publication Number Publication Date
BR112021014944A2 true BR112021014944A2 (pt) 2021-11-09

Family

ID=65443641

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112021014944A BR112021014944A2 (pt) 2019-01-30 2020-01-30 Toxinas apxia, apxiia e apxiiia inativas

Country Status (8)

Country Link
EP (2) EP3689373A1 (pt)
JP (1) JP2022519204A (pt)
KR (1) KR20210141464A (pt)
CN (1) CN113490506A (pt)
BR (1) BR112021014944A2 (pt)
CO (1) CO2021010786A2 (pt)
MX (1) MX2021009105A (pt)
WO (1) WO2020157222A1 (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB202011902D0 (en) * 2020-07-30 2020-09-16 Imperial College Innovations Ltd Antinobacillus pleuropneumoniae vaccines
CN112704732B (zh) * 2020-12-24 2022-02-25 华中农业大学 一种猪传染性胸膜肺炎放线杆菌亚单位疫苗
KR20230171941A (ko) * 2021-03-19 2023-12-21 고쿠리츠다이가쿠호진 미에다이가쿠 급성 폐손상 및 폐섬유증의 급성 악화를 개선하기 위한 의약 조성물
CN113416666A (zh) * 2021-04-27 2021-09-21 华中农业大学 猪胸膜肺炎放线杆菌血清10型突变菌株、ApxIA蛋白及应用
CN115960184B (zh) * 2022-09-28 2023-12-12 华中农业大学 一种溶血性曼氏杆菌a6血清型白细胞毒素抗原蛋白、其抗体及应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69110082T2 (de) 1990-04-20 1995-11-09 Akzo Nobel Nv Untereinheit-Impfstoff gegen Actinobacillus Pleuropneumoniae.
US5994525A (en) * 1991-06-28 1999-11-30 Kamp; Elbarte Margriet Nucleic acid encoding Actinobacillus pleuropneumoniae cytolytic proteins
AUPN631495A0 (en) 1995-11-02 1995-11-23 Commonwealth Scientific And Industrial Research Organisation Vaccine and biological vector(I)
EP0810283A3 (en) 1996-05-31 1997-12-10 Akzo Nobel N.V. Live attenuated RTX-procucing bacteria of the family Pasteurellaceae
US6770275B1 (en) * 1996-05-31 2004-08-03 Akzo Nobel N.V. Live attenuated RTC-producing bacteria of the family
ES2233145B1 (es) 2002-11-20 2006-07-16 Laboratorios Hipra, S.A. Vacuna viva atenuada contra la pleuroneumonia porcina.
CN101265457B (zh) * 2007-07-20 2011-01-26 华中农业大学 区分疫苗免疫和野毒感染动物的猪胸膜肺炎放线杆菌血清7型双基因缺失突变株的疫苗及应用
ES2416154B1 (es) * 2011-11-09 2015-04-01 Laboratorios Hipra, S.A. Cepa viva atenuada de Actinobacillus pleuropneumoniae

Also Published As

Publication number Publication date
WO2020157222A1 (en) 2020-08-06
CN113490506A (zh) 2021-10-08
EP3689373A1 (en) 2020-08-05
CO2021010786A2 (es) 2021-10-29
WO2020157222A8 (en) 2021-09-10
MX2021009105A (es) 2021-09-08
JP2022519204A (ja) 2022-03-22
KR20210141464A (ko) 2021-11-23
EP3897707A1 (en) 2021-10-27

Similar Documents

Publication Publication Date Title
BR112021014944A2 (pt) Toxinas apxia, apxiia e apxiiia inativas
BR112019012343A2 (pt) anticorpos il-11ra
CL2022000448A1 (es) Autoinyector (divisional solicitud no. 201903061)
CY1122653T1 (el) Αντισωματα αντι-τιgιτ, αντισωματα αντι-ρvrig και συνδυασμοι εξ αυτων
BR112019012342A2 (pt) anticorpos il-11
BR112018001955A2 (pt) anticorpos monoclonais contra bcma
BR112018072663A2 (pt) moduladores da via integrada ao estresse
CL2017003240A1 (es) Anticuerpos anti-rnf43 novedosos y métodos para su uso
BR112016016916A8 (pt) uso de um anticorpo que se liga à calicreína plasmática ativa para tratamento de angiodema hereditário (hae)
BR112018014355A2 (pt) processos para a preparação de f-benzoxazinorifamicina i e para a preparação de 2-amino-5-fluorobenzeno-1,3-diol iii
BR112017016897A2 (pt) cepas fúngicas e métodos de uso
CO2021002954A2 (es) Anticuerpos anti-αvβ8 y composiciones y usos de los mismos
BR112018010279A2 (pt) novos anticorpos anti-emr2 e métodos de uso
CO2018001599A2 (es) Un inhibidor de anticuerpo monoclonal de factor xiia
MX2020010881A (es) Construcciones de anticuerpos anti-ror.
BR112018070497A2 (pt) métodos e formulações farmacêuticas para tratamento de condições oculares
BR112022012731A2 (pt) Anticorpo anti-ox40 e uso do mesmo
CL2019003167A1 (es) Proteínas de unión al antígeno anti-jagged1.
BR112018012884A2 (pt) novos anticorpos anti-mmp16 e métodos de uso
BR112018071586A2 (pt) uso de beta-agonistas da tireoide
BR112021013206A2 (pt) Bibliotecas de peptídeos e respectivos métodos de uso
BR112022009587A2 (pt) Anticorpo anti-pcsk9 e uso do mesmo
AR120886A1 (es) Anticuerpos anti-fgfr2b
AR120884A1 (es) Anticuerpos anti-fgfr2b
AR120883A1 (es) Anticuerpos anti-fgfr2b